Page last updated: 2024-08-21

thiazoles and Neoplasms, Vascular

thiazoles has been researched along with Neoplasms, Vascular in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amiel, J; Berteloot, L; Blanc, E; Blanc, T; Boccara, O; Boddaert, N; Bole-Feysot, C; Broissand, C; Canaud, G; Chaussain, C; Cormier-Daire, V; Duong, JP; Grenier, N; Guibaud, L; Hoguin, C; Johnson, SC; Joly, D; Knebelmann, B; Ladraa, S; Laroche-Raynaud, C; Legendre, C; Lyonnet, S; Magassa, S; Martinez, F; Merville, P; Michot, C; Pannier, S; Picard, A; Rabia, SH; Sadoine, J; Sarnacki, S; Slimani, L; Soupre, V; Terzi, F; Venot, Q; Yamaguchi, J1
Coindre, JM; Debiec-Rychter, M; Dewaele, B; Finalet-Ferreiro, J; Fletcher, CD; Floris, G; Guillou, L; Hogendoorn, PC; Marynen, P; Schöffski, P; Sciot, R; Vandenberghe, P; Vanspauwen, V; Wozniak, A1
Bleavins, MR; de la Iglesia, FA; Dethloff, LA; Duddy, SK; Gorospe, S; Gough, AW; Parker, RF; Rowse, PE1
Bleavins, MR; de la Iglesia, FA; Duddy, SK; Gorospe, SM1

Trials

1 trial(s) available for thiazoles and Neoplasms, Vascular

ArticleYear
Targeted therapy in patients with PIK3CA-related overgrowth syndrome.
    Nature, 2018, Volume: 558, Issue:7711

    Topics: Adult; Animals; Child; Class I Phosphatidylinositol 3-Kinases; Disease Models, Animal; Female; Heart Failure; HeLa Cells; Humans; Lipoma; Male; Mice; Molecular Targeted Therapy; Musculoskeletal Abnormalities; Nevus; Phenotype; Scoliosis; Sirolimus; Syndrome; Thiazoles; Vascular Malformations; Vascular Neoplasms

2018

Other Studies

3 other study(ies) available for thiazoles and Neoplasms, Vascular

ArticleYear
Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma.
    Cancer research, 2010, Sep-15, Volume: 70, Issue:18

    Topics: Adult; Aged; Benzamides; Comparative Genomic Hybridization; Dasatinib; ErbB Receptors; Female; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Karyotyping; Male; Middle Aged; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Sarcoma; Thiazoles; Tunica Intima; Vascular Neoplasms

2010
p53 is not inactivated in B6C3F1 mouse vascular tumors arising spontaneously or associated with long-term administration of the thiazolidinedione troglitazone.
    Toxicology and applied pharmacology, 1999, Apr-15, Volume: 156, Issue:2

    Topics: Animals; Antioxidants; Chromans; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genes, p53; Hemangioma; Hemangiosarcoma; Immunohistochemistry; Male; Mice; Mice, Inbred Strains; Sequence Analysis, DNA; Thiazoles; Thiazolidinediones; Troglitazone; Vascular Neoplasms

1999
Spontaneous and thiazolidinedione-induced B6C3F1 mouse hemangiosarcomas exhibit low ras oncogene mutation frequencies.
    Toxicology and applied pharmacology, 1999, Oct-15, Volume: 160, Issue:2

    Topics: Animals; Carcinogens; Chromans; DNA, Neoplasm; Evolution, Molecular; Female; Genes, ras; Hemangiosarcoma; Male; Mice; Mice, Inbred Strains; Mutation; Polymerase Chain Reaction; Sequence Analysis; Thiazoles; Thiazolidinediones; Troglitazone; Vascular Neoplasms

1999